Contract notice
Section I: Contracting
authority
I.1) Name and addresses
UK Biobank Ltd
1-2 Spectrum Way, Adswood
Stockport
SK3 0SA
UK
Contact person: Andrea Howard
Telephone: +44 1614755386
E-mail: tenders@ukbiobank.ac.uk
NUTS: UKD35
Internet address(es)
Main address: http://www.ukbiobank.ac.uk
Address of the buyer profile: https://www.mytenders.co.uk/search/Search_AuthProfile.aspx?ID=AA25607
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://www.mytenders.co.uk/search/Search_AuthProfile.aspx?ID=AA25607
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://www.mytenders.co.uk/search/Search_AuthProfile.aspx?ID=AA25607
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Whole Genome Sequencing
Reference number: UKBB005
II.1.2) Main CPV code
85148000
II.1.3) Type of contract
Services
II.1.4) Short description
UK Biobank requires a single sequencing provider that can offer Whole Genome Sequencing (WGS) services that meet the requirements outlined in the specification.
The key parameters for any bidder are as follows:
— There is up to GBP 30m funding available for the conduct of a vanguard phase of whole genome sequencing,
— The scope of the tender is for sequencing (and certain named ancillary) services only,
— The sequencing for this vanguard phase should ideally be completed by the end of 2019.
II.1.5) Estimated total value
Value excluding VAT:
30 000 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
UKD3
II.2.4) Description of the procurement
This procurement is being conducted under regulation 74 of the Public Contracts Regulations 2015 (as amended) as a light touch procedure, although we are voluntarily adopting a process akin to the open procedure. UK Biobank is issuing this tender to invite bids to conduct a vanguard phase of whole genome sequencing. The principal purpose of this vanguard phase is to inform and develop the protocols and processes for the whole genome sequencing of all UK Biobank’s 500 000 participants which is expected to take place (subject to confirmation of funding) in the next few years.
UK Biobank is a major national health resource, and a registered charity in its own right, with the aim of improving the prevention, diagnosis and treatment of a wide range of serious and life-threatening illnesses – including cancer, heart diseases, stroke, diabetes, arthritis, osteoporosis, eye disorders, depression and forms of dementia.
UK Biobank recruited 500 000 people aged between 40-69 years in 2006-2010 from across the country to take part in this project. They have undergone measures, provided blood, urine and saliva samples for future analysis, given detailed information about themselves and agreed to have their health followed. Over many years this will build into a powerful resource to help scientists discover why some people develop particular diseases and others do not.
II.2.5) Award criteria
Criteria below:
Quality criterion: Technical Requirements
/ Weighting: 65 %
Quality criterion: Scale
/ Weighting: 5 %
Quality criterion: Collaboration
/ Weighting: 20 %
Price
/ Weighting:
10 %
II.2.6) Estimated value
Value excluding VAT:
30 000 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 36
This contract is subject to renewal: Yes
Description of renewals:
There may be the need to extend the duration based upon outcomes from the vanguard phase.
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
III.2) Conditions related to the contract
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
27/02/2018
Local time: 09:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.7) Conditions for opening of tenders
Date:
27/02/2018
Local time: 12:00
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.2) Information about electronic workflows
Electronic invoicing will be accepted
Electronic payment will be used
VI.3) Additional information
NOTE: To register your interest in this notice and obtain any additional information please visit the myTenders Web Site at http://www.myTenders.org/Search/Search_Switch.aspx?ID=206350
The buyer has indicated that it will accept electronic responses to this notice via the Postbox facility. A user guide is available at http://www.myTenders.org/sitehelp/help_guides.aspx
Suppliers are advised to allow adequate time for uploading documents and to dispatch the electronic response well in advance of the closing time to avoid any last minute problems.
(MT Ref:206350).
VI.4) Procedures for review
VI.4.1) Review body
UK Biobank Ltd
1-2 Spectrum Way, Adswood
Stockport
SK3 0SA
UK
Telephone: +44 1614755386
Internet address(es)
URL: http://www.ukbiobank.ac.uk
VI.5) Date of dispatch of this notice
26/01/2018